Following treatment with deoxyschisandrin, the BDNF protein expression in the colonic mucosa in IBD mice was decreased; this finding explains the mechanism of action for schisandrin A: a reduction in the intestinal sensitivity of mice by reducing BDNF expression in the colonic mucosa [65] (Table 2). Here, BDNF is linked to inflammatory bowel disease.